🔴 10x Genomics is trading 5% down as hotter U.S. inflation fuels rate concerns

10x Genomics is trading at $70.33, with a -4.80% change, amid broader technology weakness.

• No clear company-specific announcement explains the October 15 decline; the company’s next earnings report is scheduled for November 5.
• Reuters reported hotter-than-expected U.S. inflation heightened rate concerns and drove technology shares lower, including a more than 1% drop in Nasdaq futures. The supplied market context also shows the Nasdaq down 1.07%.